uce
ProgressImage ProgressImage
Sequent Scientific Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 512529 border-img ISIN Demat INE807F01027 border-img Book Value 42.63 border-img NSE Symbol SEQUENT border-img Div & Yield % 0 border-img Market Cap ( Cr.) 3146.6 border-img P/E 0 border-img EPS 0.06 border-img Face Value 2
Quarters
ParticularsDec 2023
()
Sep 2023
()
Jun 2023
()
Gross Sales42.2149.1240.42
Other Operating Income0.000.000.00
Other Income 13.449.879.70
Total Income55.6558.9950.12
Total Expenditure 46.3656.8255.74
PBIDT9.292.17-5.63
Interest 1.151.210.98
PBDT8.140.96-6.61
Depreciation2.052.352.43
Tax0.461.50-1.50
Fringe Benefit Tax0.000.000.00
Deferred Tax1.05-1.98-0.73
Reported Profit After Tax4.58-0.92-6.80
Extra-ordinary Items 0.000.00-6.25
Adjusted Profit After Extra-ordinary item4.58-0.92-0.55
    
EPS (Unit Curr.)0.18-0.04-0.27
EPS (Adj) (Unit Curr.)0.18-0.04-0.27
Calculated EPS (Unit Curr.)0.18-0.04-0.27
Calculated EPS (Adj) (Unit Curr.)0.18-0.04-0.27
Calculated EPS (Ann.) (Unit Curr.)0.73-0.15-1.09
Calculated EPS (Adj) (Ann.) (Unit Curr.)0.73-0.15-1.09
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity49.8949.8949.89
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)22.014.42-13.93
PBDTM(%)19.281.95-16.35
PATM(%)10.85-1.87-16.82
x
x
×
Let's Chat
close
refresh